Clinical trials
Multiple Sclerosis trials in Spain with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hospital General Universitario Gregorio Marañon | 2 |
| Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul | 1 |
| Fundació Institut Germans Trias i Pujol | 1 |
| Hospital Clínico Universitario de Valladolid | 1 |
| Hospital San Carlos, Madrid | 1 |
| Hospital Universitario de Canarias | 1 |
| Kessler Foundation | 1 |
| Universidad Europea de Madrid | 1 |
| Universidad Rey Juan Carlos | 1 |
| Universidad de Granada | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 14 |
| Multiple Sclerosis, Relapsing-Remitting | 2 |
| Brain Injuries, Traumatic | 1 |
| Demyelinating Diseases | 1 |
| Fatigue | 1 |
| Fecal Incontinence | 1 |
| Multiple Sclerosis, Chronic Progressive | 1 |
| Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease | 1 |
| Neurogenic Bowel | 1 |
| Optic Neuritis | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.